This Week's E-Edition
Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators today that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.
COVID-19 vaccine makers told Congress today to expect a big jump in the delivery of doses over the coming month after a rocky start to inoculations, and the companies insist they will be able to provide enough for most Americans by summer.
Phone line to help older adults in Dubuque County with COVID-19 vaccines
Some 260 more Dubuque County residents have received their first dose of the COVID-19 vaccine as of Tuesday, according to new data from the state, pushing the total who have received just the first dose over 8,000.
U.S. scientists would gain vastly expanded capabilities to identify potentially deadlier coronavirus mutations under legislation advancing in Congress. A House bill headed for floor debate would provide $1.75 billion for genomic sequencing.
- Council votes to purchase new police car
- Noonan captures his third state title
- Cougars fall to Beckman, 50-47
- Anamosa ends Cascade's season
- Retired Cascade teacher continues to substitute out of a love for teaching
- Cougar cheer squad perseveres in spite of small pandemic audiences
- Johnson & Johnson’s single-dose COVID-19 shot poised for FDA decision
- Drug executives: Big jump in vaccine supply is coming soon